Successful carotid endarterectomy in a patient with factor XII deficiency (Hageman disease): a case report
DOI:
https://doi.org/10.14739/2310-1210.2025.4.324458Keywords:
carotid endarterectomy, factor XII deficiency, Hageman disease, carotid stenosis, coagulopathy, case reportAbstract
Aim. To present the first documented case of successful carotid endarterectomy in a patient with severe Factor XII deficiency and analyze the features of perioperative management.
Materials and methods. We report a case of a 70-year-old male with critical left internal carotid artery stenosis (90 %) and incidentally discovered severe Factor XII deficiency (activity 0.1 %, activated partial thromboplastin time (aPTT) 235.0 seconds) during preoperative screening. A comprehensive differential diagnosis of prolonged aPTT was performed, including measurement of intrinsic coagulation factor activities and immunological testing. Classical carotid endarterectomy under local anesthesia was performed using a standard perioperative thromboprophylaxis protocol.
Results. The surgery and postoperative period were uneventful with a blood loss of 150 ml. Standard thromboprophylaxis was administered using unfractionated heparin intraoperatively and low molecular weight heparin postoperatively. At 3-month follow-up, ultrasound confirmed satisfactory reconstruction with normal flow parameters.
Conclusions. Isolated factor XII deficiency is not a contraindication for carotid endarterectomy when proper preoperative diagnosis is established, and standard perioperative protocols are followed. A multidisciplinary approach involving a hematologist is essential for successful management of such patients.
References
GBD 2019 Stroke Collaborators. Global burden of stroke and risk factors, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet Neurol. 2021;20(10):795-820. doi: https://doi.org/10.1016/s1474-4422(21)00252-0
Li L, Scott CA, Rothwell PM; Oxford Vascular Study. Trends in Stroke Incidence in High-Income Countries in the 21st Century: Population-Based Study and Systematic Review. Stroke. 2020;51(5):1372-80. doi: https://doi.org/10.1161/STROKEAHA.119.028484
Mazzolai L, Teixido-Tura G, Lanzi S, Boc V, Bossone E, Brodmann M, et al. 2024 ESC Guidelines for the management of peripheral arterial and aortic diseases. Eur Heart J. 2024;45(36):3538-700. doi: https://doi.org/10.1093/eurheartj/ehae179
Naylor R, Rantner B, Ancetti S, de Borst GJ, De Carlo M, Halliday A, et al. Editor's Choice - European Society for Vascular Surgery (ESVS) 2023 Clinical Practice Guidelines on the Management of Atherosclerotic Carotid and Vertebral Artery Disease. Eur J Vasc Endovasc Surg. 2023;65(1):7-111. doi: https://doi.org/10.1016/j.ejvs.2022.04.011
Kamal AH, Tefferi A, Pruthi RK. How to interpret and pursue an abnormal prothrombin time, activated partial thromboplastin time, and bleeding time in adults. Mayo Clin Proc. 2007;82(7):864-73. doi: https://doi.org/10.4065/82.7.864
Bauça JM, Ajzner É, Cadamuro J, Hillarp A, Kristoffersen AH, Meijer P; Working Group on the Postanalytical Phase of the European Federation of Clinical Chemistry and Laboratory Medicine (EFLM). An international study on activated partial thromboplastin time prolongation. Part 1: Analytical results. Clin Chim Acta. 2022;535:167-73. doi: https://doi.org/10.1016/j.cca.2022.08.024
Ratnoff OD, Colopy JE. A familial hemorrhagic trait associated with a deficiency of a clot-promoting fraction of plasma. J Clin Invest. 1955;34(4):602-13. doi: https://doi.org/10.1172/jci103109
Konrath S, Mailer RK, Renné T. Mechanism, Functions, and Diagnostic Relevance of FXII Activation by Foreign Surfaces. Hamostaseologie. 2021;41(6):489-501. doi: https://doi.org/10.1055/a-1528-0499
Lämmle B, Wuillemin WA, Huber I, Krauskopf M, Zürcher C, Pflugshaupt R, et al. Thromboembolism and bleeding tendency in congenital factor XII deficiency--a study on 74 subjects from 14 Swiss families. Thromb Haemost. 1991;65(2):117-21. doi: https://doi.org/10.1055/s-0038-1647467
Kalinin DV. Factor XII(a) inhibitors: a review of the patent literature. Expert Opin Ther Pat. 2021;31(12):1155-76. doi: https://doi.org/10.1080/13543776.2021.1945580
Schmaier AH, Stavrou EX. Factor XII - What's important but not commonly thought about. Res Pract Thromb Haemost. 2019;3(4):599-606. doi: https://doi.org/10.1002/rth2.12235
Mailer RK, Rangaswamy C, Konrath S, Emsley J, Renné T. An update on factor XII-driven vascular inflammation. Biochim Biophys Acta Mol Cell Res. 2022;1869(1):119166. doi: https://doi.org/10.1016/j.bbamcr.2021.119166
Wheeler AP, Gailani D. Why factor XII deficiency is not protected from thrombosis. Arterioscler Thromb Vasc Biol. 2016;36(6):1053-5. doi: https://doi.org/10.1080/17474086.2016.1191944
Girolami A, Randi ML, Gavasso S, Lombardi AM, Spiezia F. The occasional venous thromboses seen in patients with severe (homozygous) FXII deficiency are probably due to associated risk factors: a study of prevalence in 21 patients and review of the literature. J Thromb Thrombolysis. 2004;17(2):139-43. doi: https://doi.org/10.1023/b:thro.0000037670.42776.cd
Eikelboom JW, Connolly SJ, Bosch J, Dagenais GR, Hart RG, Shestakovska O, et al. COMPASS Investigators. Rivaroxaban with or without Aspirin in Stable Cardiovascular Disease. N Engl J Med. 2017;377(14):1319-30. doi: https://doi.org/10.1056/nejmoa1709118
Bonaca MP, Bauersachs RM, Anand SS, Debus ES, Nehler MR, Patel MR, et al. Rivaroxaban in Peripheral Artery Disease after Revascularization. N Engl J Med. 2020;382(21):1994-2004. doi: https://doi.org/10.1056/nejmoa2000052
Downloads
Additional Files
Published
How to Cite
Issue
Section
License
Copyright (c) 2025 M. O. Slabyi, H. Yu. Orel, O. M. Slabyi
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish with this journal agree to the following terms:
Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal. 
